UNIVERSITE PARIS DESCARTES
Patent Owner
Stats
- 63 US PATENTS IN FORCE
- 31 US APPLICATIONS PENDING
- Mar 15, 2018 most recent publication
Details
- 63 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 989 Total Citation Count
- Jan 13, 1984 Earliest Filing
- 84 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0362,302 Method and Pharmaceutical Composition for Use in the Treatment of CancerAug 28, 17Dec 21, 17[A61K, C07K]
2017/0313,758 Polypeptides for the Treatment of Angiogenesis or Lymphangiogenesis-Related DiseasesNov 24, 15Nov 02, 17[A61K, C12N, C07K]
2017/0246,631 Microfluidic Device With One Microchannel for Multiple DetectionOct 13, 15Aug 31, 17[B01L, G01N]
2017/0209,488 METHODS FOR TREATING NEUROMUSCULAR JUNCTION-RELATED DISEASESJul 16, 15Jul 27, 17[A61K]
2017/0183,306 CYCLIC COMPOUNDS HAVING A 1,3 DIAMINO-FUNCTIONALITY FOR USE IN THE TREATMENT OF HIV INFECTIONMay 29, 15Jun 29, 17[A61K, C07D]
2017/0175,207 METHODS FOR PREDICTING THE OUTCOME OF A CANCER IN A PATIENT BY ANALYSING GENE EXPRESSIONMar 01, 17Jun 22, 17[C12Q, G06F]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9909977 Simultaneous monitoring of fibrinogen and haematocrit in whole bloodOct 15, 14Mar 06, 18[G01N]
9861615 Methods and pharmaceutical compositions for the treatment of beta-thalassemiasNov 28, 14Jan 09, 18[A61K, C07D, G01N]
9851357 Method for the prognosis of survival time of a patient suffering from a solid cancerJul 11, 14Dec 26, 17[G01N]
9851363 Method for monitoring cancer and/or inflammatory reaction based on RelB phosphorylationApr 18, 14Dec 26, 17[G01N, C07K]
9839684 Pharmaceutical compositions comprising inactivated HIV viral particles and non-pathogenic lactobacilli for the induction of antigen-specific immunotoleranceApr 06, 12Dec 12, 17[A61K]
9834820 Methods for the treatment and diagnosis of bone mineral density related diseasesDec 19, 14Dec 05, 17[A61K, C12Q]
9777272 Methods for the treatment of Leber congenital amaurosisSep 16, 16Oct 03, 17[A61K, C07H, C12N]
9771584 Methods for the prevention and the treatment of extracapillary glomerulonephritisJan 22, 15Sep 26, 17[A61K, C07H, C12Q, C12N, G01N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0281,176 METHOD FOR PREDICTING THE OUTCOME OF COLON CANCER BY ANALYSING MIRNA EXPRESSIONAbandonedMay 26, 16Sep 29, 16[C12Q]
2016/0185,827 VACCINES FOR PREVENTING MENINGOCOCCAL INFECTIONSAbandonedMar 09, 16Jun 30, 16[A61K, C07K]
2016/0051,674 METHODS AND PHARMACEUTICAL COMPOSITIONS (CTPS 1 INHIBITORS, E.G. NORLEUCINE) FOR INHIBITING T CELL PROLIFERATION IN A SUBJECT IN NEED THEREOFAbandonedApr 17, 14Feb 25, 16[A61K, G01N]
2016/0032,382 Method for Diagnosing or Predicting a Non Syndromic Autosomal Recessive Optic Atrophy, or a Risk of a Non Syndromic Autosomal Recessive Optic AtrophyAbandonedApr 29, 15Feb 04, 16[C12Q, C07K]
2015/0342,876 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OCULAR INFLAMMATORY DISEASESAbandonedAug 11, 15Dec 03, 15[A61K]
2015/0323,550 METHOD FOR THE DIAGNOSIS OF SYSTEMIC SCLERODERMA OR OF PULMONARY ARTERIAL HYPERTENSIONAbandonedApr 14, 15Nov 12, 15[G01N]
2015/0299,798 METHOD FOR CLASSIFICATION OF LIVER SAMPLES AND DIAGNOSIS OF FOCAL NODULE DYSPLASIA, HEPATOCELLULAR ADENOMA, AND HEPATOCELLULAR CARCINOMAAbandonedSep 23, 13Oct 22, 15[C12Q, G06F]
2015/0297,628 METHODS FOR THE TREATMENT AND DIAGNOSIS OF ATHEROSCLEROSISAbandonedJun 25, 15Oct 22, 15[A61K, C12Q]
2015/0247,196 IN VITRO GENETIC DIAGNOSTIC OF INHERITED NEUROMUSCULAR DISORDERSAbandonedSep 06, 13Sep 03, 15[C12Q]
2015/0232,944 METHOD FOR PROGNOSIS OF GLOBAL SURVIVAL AND SURVIVAL WITHOUT RELAPSE IN HEPATOCELLULAR CARCINOMAAbandonedSep 23, 13Aug 20, 15[C12Q, G06F]
2015/0225,799 METHODS FOR PREDICTING THE OUTCOME OF A CANCER IN A PATIENT BY ANALYSING GENE EXPRESSIONAbandonedApr 24, 15Aug 13, 15[C12Q, G06F]
2015/0197,574 USE OF TRANSFERRIN RECEPTOR ANTAGONIST FOR THE TREATMENT OF THALASSEMIAAbandonedAug 02, 13Jul 16, 15[C07K]
2015/0104,463 METHODS AND KITS FOR PREDICTING THE RISK OF HAVING A CARDIOVASCULAR EVENT IN A SUBJECTAbandonedDec 22, 14Apr 16, 15[G01N, C07K]
2015/0105,281 Method for the Selection of Serum Biomarkers of Epigenetic Alterations, Particularly of Global Hypomethylation and Their UsesAbandonedApr 17, 13Apr 16, 15[C12Q, G01N]
2015/0105,329 Methods and Pharmaceutical Compositions for Prevention or Treatment of Ischemia Related Organ DamageAbandonedMar 26, 13Apr 16, 15[A61K]
2015/0094,229 METHODS FOR THE SCREENING OF ANTIBACTERIAL SUBSTANCESAbandonedOct 07, 14Apr 02, 15[C12Q, G01N]
2015/0017,203 COMBINATION PRODUCT FOR TREATING EXCESS WEIGHT AND/OR FOR IMPROVING THE FIGUREAbandonedFeb 28, 13Jan 15, 15[A61K]
2015/0011,560 ANTAGONIST OF THE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3) FOR USE IN THE TREATMENT OR THE PREVENTION OF SKELETAL DISORDERS LINKED WITH ABNORMAL ACTIVATION OF FGFR3AbandonedDec 12, 12Jan 08, 15[A61K]
2014/0288,156 METHODS FOR THE TREATMENT AND DIAGNOSIS OF ATHEROSCLEROSISAbandonedOct 29, 12Sep 25, 14[C12Q, C12N]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.